Cubist Systematic Strategies’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-198,373
| Closed | -$1.9M | – | 3009 |
|
|
2024
Q4 | $1.9M | Sell |
198,373
-132,107
| -40% | -$1.21M | 0.01% | 1391 |
|
|
2024
Q3 | $2.76M | Buy |
330,480
+310,760
| +1,576% | +$2.82M | 0.02% | 1230 |
|
|
2024
Q2 | $134K | Sell |
19,720
-21,668
| -52% | -$93.2K | ﹤0.01% | 2582 |
|
|
2024
Q1 | $105K | Sell |
41,388
-461,851
| -92% | -$1.04M | ﹤0.01% | 3253 |
|
|
2023
Q4 | $1.21M | Buy |
503,239
+163,545
| +48% | +$384K | 0.01% | 1904 |
|
|
2023
Q3 | $1.15M | Buy |
339,694
+181,879
| +115% | +$1.01M | 0.01% | 1779 |
|
|
2023
Q2 | $1.16M | Sell |
157,815
-5,898
| -4% | -$54.7K | 0.01% | 1866 |
|
|
2023
Q1 | $1.7M | Buy |
163,713
+42,748
| +35% | +$517K | 0.01% | 1788 |
|
|
2022
Q4 | $1.43M | Buy |
120,965
+17,549
| +17% | +$272K | 0.01% | 2141 |
|
|
2022
Q3 | $2.17M | Buy |
103,416
+82,227
| +388% | +$2.29M | 0.01% | 1924 |
|
|
2022
Q2 | $658K | Sell |
21,189
-63,424
| -75% | -$2.17M | ﹤0.01% | 2832 |
|
|
2022
Q1 | $3.47M | Sell |
84,613
-16,323
| -16% | -$720K | 0.03% | 1029 |
|
|
2021
Q4 | $4.39M | Buy |
100,936
+86,046
| +578% | +$3.89M | 0.04% | 750 |
|
|
2021
Q3 | $746K | Sell |
14,890
-31,406
| -68% | -$1.9M | 0.01% | 1746 |
|
|
2021
Q2 | $2.92M | Buy |
46,296
+26,740
| +137% | +$1.72M | 0.03% | 850 |
|
|
2021
Q1 | $1.82M | Buy |
19,556
+6,113
| +45% | +$626K | 0.02% | 1103 |
|
|
2020
Q4 | $1.2M | Sell |
13,443
-42,125
| -76% | -$3.87M | 0.02% | 1257 |
|
|
2020
Q3 | $5.74M | Buy |
55,568
+52,150
| +1,526% | +$5.62M | 0.09% | 346 |
|
|
2020
Q2 | $270K | Sell |
3,418
-17,019
| -83% | -$1.27M | ﹤0.01% | 1891 |
|
|
2020
Q1 | $1.18M | Sell |
20,437
-6,075
| -23% | -$350K | 0.03% | 732 |
|
|
2019
Q4 | $1.43M | Sell |
26,512
-2,738
| -9% | -$149K | 0.03% | 938 |
|
|
2019
Q3 | $1.53M | Buy |
29,250
+18,517
| +173% | +$863K | 0.03% | 760 |
|
|
2019
Q2 | $519K | Buy |
+10,733
| New | +$514K | 0.01% | 1450 |
|
|
2019
Q1 | – | Sell |
-6,654
| Closed | -$394K | – | 2286 |
|
|
2018
Q4 | $394K | Buy |
+6,654
| New | +$429K | 0.02% | 1101 |
|
|
2018
Q3 | – | Sell |
-4,626
| Closed | -$234K | – | 1930 |
|
|
2018
Q2 | $234K | Sell |
4,626
-247
| -5% | -$12.9K | 0.01% | 1242 |
|
|
2018
Q1 | $257K | Sell |
4,873
-8,322
| -63% | -$415K | 0.02% | 1250 |
|
|
2017
Q4 | $613K | Buy |
13,195
+7,407
| +128% | +$312K | 0.03% | 760 |
|
|
2017
Q3 | $234K | Buy |
+5,788
| New | +$209K | 0.01% | 1340 |
|
|
2017
Q1 | – | Sell |
-18,077
| Closed | -$594K | – | 1676 |
|
|
2016
Q4 | $594K | Buy |
+18,077
| New | +$542K | 0.05% | 589 |
|
|
2016
Q3 | – | Sell |
-12,912
| Closed | -$363K | – | 1730 |
|
|
2016
Q2 | $363K | Buy |
12,912
+7,386
| +134% | +$290K | 0.02% | 964 |
|
|
2016
Q1 | $201K | Buy |
+5,526
| New | +$195K | 0.01% | 1218 |
|
Other funds holding EBS
PCM
OHA
Cubist Systematic Strategies's EBS Position: Q1 2025 in Review
Cubist Systematic Strategies sold out of Emergent Biosolutions (EBS) in Q1 2025, closing a stake of 198,373 shares — an estimated $1.9M sold.
Cubist Systematic Strategies first reported a position in EBS in Q1 2016 and held it in 31 quarters. The position peaked at $5.74M in Q3 2020. 160 funds tracked by Wall St. Rank hold EBS as of Q1 2025.
- Cubist Systematic Strategies reported no remaining Emergent Biosolutions position as of Q1 2025 after selling out during the quarter.
- Cubist Systematic Strategies sold 198,373 Emergent Biosolutions shares in Q1 2025, an estimated $1.9M.
- Cubist Systematic Strategies first reported a position in Emergent Biosolutions in Q1 2016 and held it in 31 quarters.
- Cubist Systematic Strategies's Emergent Biosolutions position peaked at $5.74M in Q3 2020.
- 160 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2025.
Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.